Samsung Biologics Reports First Quarter 2026 Financial Results Recorded Q1’26 revenue of KRW 1,257 billion and operating profit of KRW… CISION PRNewswireApril 22, 2026
Press ReleaseOne Heung Kong Teams Up with Guangdong Fashion Week to Empower Chinese Original Design to Go Global GUANGZHOU, China, April 22, 2026 /PRNewswire/ — From April 17 to 24,… CISION PRNewswireApril 22, 2026
Press ReleaseNEW TELE-DENTISTRY PROGRAMME SUPPORTS EARLY INTERVENTION FOR CHILDREN AT RISK OF CARIES Targeting vulnerable families, the collaborative programme empowers parents with personalised insights and… CISION PRNewswireApril 22, 2026
OpenAI's GPT Image 2 Is Now Available on Pollo AI SINGAPORE, April 22, 2026 /PRNewswire/ — Pollo AI today announced the availability… CISION PRNewswireApril 22, 2026
Press ReleaseLingnan ICH Shines on the Global Haute Couture Stage: One Heung Kong and Guangdong Fashion Week Forge a New Paradigm for Chinese Original Design GUANGZHOU, China, April 22, 2026 /PRNewswire/ — As the global fashion industry undergoes… CISION PRNewswireApril 22, 2026
AscendCare Medical Clinic Launches Public Awareness Initiative to Normalise Regular Health Screening in Singapore SINGAPORE, April 22, 2026 /PRNewswire/ — AscendCare Medical Clinic, a modern healthcare… CISION PRNewswireApril 22, 2026
ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15' ImmunoForge’s LMT15 Platform combines high BBB permeability with proprietary long-acting ELP technology… CISION PRNewswireApril 22, 2026
2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation SUZHOU, China, April 22, 2026 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) today… CISION PRNewswireApril 22, 2026